Shanghai Chest Hospital

This study is testing whether a combination of two drugs, SHR-A1811 and adebelimumab, can shrink tumors before surgery in people with early-stage, operable lung cancer that has a specific genetic change called HER2. The goal is to see if this pre-surgery treatment helps remove mo…

This study is testing whether a common type 2 diabetes pill (SGLT2 inhibitor) can help people who have both advanced lung cancer and diabetes. Researchers want to see if adding this pill to standard cancer treatment helps patients live longer or slows the cancer's growth. They wi…

This study is testing whether adding the drug dapagliflozin around the time of a heart ablation procedure can help prevent the irregular heartbeat from coming back. It will involve 280 adults with a specific type of long-lasting atrial fibrillation who have extra fat around the h…

This study is testing whether a medication for heart failure and high blood pressure (sacubitril/valsartan) can help people who have both advanced lung cancer and high blood pressure live longer. Researchers will follow 200 participants to see if the drug reduces deaths and serio…

This study is testing a new treatment approach for a rare chest cancer called locally advanced thymic carcinoma. It aims to see if giving a combination of immunotherapy, chemotherapy, and radiation *before* surgery can shrink tumors and make them easier to remove. The trial will …

This study tests whether adding a kidney nerve treatment to a standard heart procedure helps prevent early irregular heartbeats in people with persistent atrial fibrillation. Researchers will compare the combined treatment against the standard procedure alone in 86 adults who are…

This study is testing a new mobile 4D imaging scanner to see if it helps doctors get better pictures of small lung lesions during a biopsy procedure. About 50 adults with lung lesions will have their scans taken with this device during a standard bronchoscopy. The main goal is to…